William Blair & Company
PETX

William Blair & Company’s Aratana Therapeutics, Inc. PETX Stock Holding History

William Blair & Company’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-61,500
Closed -$445K – 1567
2017
Q2 		$445K Buy
61,500
+16,500
+37% +$101K ﹤0.01% 1017
2017
Q1 		$239K Buy
+45,000
New +$304K ﹤0.01% 1159

Other funds holding PETX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

William Blair & Company's PETX Position: Q3 2019 in Review

William Blair & Company sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 143,710 shares — an estimated $742K sold.

William Blair & Company first reported a position in PETX in Q4 2013 and held it in 23 quarters. The position peaked at $7.82M in Q1 2014. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • William Blair & Company reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • William Blair & Company sold 143,710 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $742K.
  • William Blair & Company first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 23 quarters.
  • William Blair & Company's Aratana Therapeutics, Inc. position peaked at $7.82M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on William Blair & Company's 13F filing for Q3 2019, filed 12 Nov 2019.